Live
FierceBiotechAstraZeneca pens agentic AI licensing deal with Owkin10x Genomics BlogWhy 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance10x Genomics Blog10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News10x Genomics News10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology NewsScience Daily BiotechA rare cancer-fighting plant compound has been decodedEli LillyEli Lilly Clinical Trial Shows Its Obesity Drugs Can Cause Weight Loss And Help Maintain It - StocktwitsEndpoints NewsLilly points to low-dose Zepbound and Foundayo as weight loss maintenance optionsIlluminaThe Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.stSiemens HealthineersA Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership - simplywall.stLabCorpLabcorp and Epic Expand Collaboration for Lab Test Ordering - Clinical Lab ProductsFierceBiotechFDA Commissioner Marty Makary to resign, capping turbulent tenure: reportFierceBiotechKyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
FierceBiotech Mar 28, 2026

Takeda clears path to FDA with phase 3 data on $4B psoriasis bet

Takeda clears path to FDA with phase 3 data on $4B psoriasis bet

Original
Body unavailable. Use the original source.